drugset / Trial / NCT01494311
Rapydan Topical Anaesthesia for Arterial Cannulation
Phase 4
Completed
90 enrolled
Medical University of Vienna
Population Health Research Institute · collabThe Cleveland Clinic · collab
RandomizedParallel-groupTriple-blindSupportive care
Summary
Arterial catheterization is painful and is associated with patient stress and anxiety. Analgesia is usually provided by subcutaneous injection of local anesthetic. An alternative is topical anaesthesia, such as Rapydan which is a novel topical anesthetic patch containing 70 mg each of lidocaine and tetracaine. We therefore tested the hypothesis that Rapydan patch analgesia is non-inferior to subcutaneous local anesthetic.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-06
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 0.5 ml | Topical |
| Subject | Lidocaine | Other / unclassified | 70 mg | Topical |
| Subject | tetracaine | Other / unclassified | 70 mg | Topical |
Indications
No indication recorded.